Literature DB >> 21030659

A size threshold limits prion transmission and establishes phenotypic diversity.

Aaron Derdowski1, Suzanne S Sindi, Courtney L Klaips, Susanne DiSalvo, Tricia R Serio.   

Abstract

According to the prion hypothesis, atypical phenotypes arise when a prion protein adopts an alternative conformation and persist when that form assembles into self-replicating aggregates. Amyloid formation in vitro provides a model for this protein-misfolding pathway, but the mechanism by which this process interacts with the cellular environment to produce transmissible phenotypes is poorly understood. Using the yeast prion Sup35/[PSI(+)], we found that protein conformation determined the size distribution of aggregates through its interactions with a molecular chaperone. Shifts in this range created variations in aggregate abundance among cells because of a size threshold for transmission, and this heterogeneity, along with aggregate growth and fragmentation, induced age-dependent fluctuations in phenotype. Thus, prion conformations may specify phenotypes as population averages in a dynamic system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030659      PMCID: PMC3003433          DOI: 10.1126/science.1197785

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids.

Authors:  Aleksandra B Salnikova; Dmitry S Kryndushkin; Vladimir N Smirnov; Vitaly V Kushnirov; Michael D Ter-Avanesyan
Journal:  J Biol Chem       Date:  2004-12-23       Impact factor: 5.157

Review 2.  [PSI+]: an epigenetic modulator of translation termination efficiency.

Authors:  T R Serio; S L Lindquist
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

3.  Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae.

Authors:  I L Derkatch; Y O Chernoff; V V Kushnirov; S G Inge-Vechtomov; S W Liebman
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

Review 4.  Prion-like transmission of protein aggregates in neurodegenerative diseases.

Authors:  Patrik Brundin; Ronald Melki; Ron Kopito
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04       Impact factor: 94.444

5.  The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3.

Authors:  P Zhou; I L Derkatch; S M Uptain; M M Patino; S Lindquist; S W Liebman
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

6.  The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.

Authors:  H K Edskes; V T Gray; R B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast.

Authors:  Frédérique Ness; Paulo Ferreira; Brian S Cox; Mick F Tuite
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  Analysis of the generation and segregation of propagons: entities that propagate the [PSI+] prion in yeast.

Authors:  Brian Cox; Frederique Ness; Mick Tuite
Journal:  Genetics       Date:  2003-09       Impact factor: 4.562

9.  Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.

Authors:  Dmitry S Kryndushkin; Ilya M Alexandrov; Michael D Ter-Avanesyan; Vitaly V Kushnirov
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  56 in total

1.  Localization of HET-S to the cell periphery, not to [Het-s] aggregates, is associated with [Het-s]-HET-S toxicity.

Authors:  Vidhu Mathur; Carolin Seuring; Roland Riek; Sven J Saupe; Susan W Liebman
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

Review 2.  Patterns of [PSI (+) ] aggregation allow insights into cellular organization of yeast prion aggregates.

Authors:  Jens Tyedmers
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Study of Amyloids Using Yeast.

Authors:  Reed B Wickner; Dmitry Kryndushkin; Frank Shewmaker; Ryan McGlinchey; Herman K Edskes
Journal:  Methods Mol Biol       Date:  2018

4.  Structural variants of yeast prions show conformer-specific requirements for chaperone activity.

Authors:  Kevin C Stein; Heather L True
Journal:  Mol Microbiol       Date:  2014-08-21       Impact factor: 3.501

Review 5.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

6.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 7.  Defining the limits: Protein aggregation and toxicity in vivo.

Authors:  William M Holmes; Courtney L Klaips; Tricia R Serio
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-04-28       Impact factor: 8.250

Review 8.  Amyloids or prions? That is the question.

Authors:  Raimon Sabate; Frederic Rousseau; Joost Schymkowitz; Cristina Batlle; Salvador Ventura
Journal:  Prion       Date:  2015       Impact factor: 3.931

9.  A small, glutamine-free domain propagates the [SWI(+)] prion in budding yeast.

Authors:  Emily T Crow; Zhiqiang Du; Liming Li
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

10.  A Discrete-Time Branching Process Model of Yeast Prion Curing Curves.

Authors:  Suzanne S Sindi; Peter Olofsson
Journal:  Math Popul Stud       Date:  2013-01-27       Impact factor: 0.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.